Back to top

Image: Bigstock

Pfizer (PFE) Catches Eye: Stock Jumps 9%

Read MoreHide Full Article

Pfizer Inc. (PFE - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $30.02 –$36.40 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Pfizer currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Pfizer Inc. Price

Pfizer Inc. Price

Pfizer Inc. price | Pfizer Inc. Quote

Investors interested in the Medical sector may consider Regeneron Pharmaceuticals, Inc. (REGN - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PFE going up? Or down? Predict to see what others think:Up or Down

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Regeneron Pharmaceuticals, Inc. (REGN) - free report >>

Pfizer Inc. (PFE) - free report >>

Published in